Bivictrix Therapeutics PLC on Wednesday - Macclesfield, England-based biotechnology company focusing on cancer therapies - Announces a proposed fundraise of over £2 million by way of a conditional placing to investors. The placing will raise £1.2 million before expenses through the issue of 9.2 million shares at 13 pence per share. Adds the subscription of shares will raise around £800,000 before expenses through the issue of 6.8 million new shares. Says issue of shares is subject to shareholder approval at the general meeting set to take place on August 8.

Current stock price: 14.70 pence, up 1.4% on Wednesday

12-month change: down 28%

Copyright 2023 Alliance News Ltd. All Rights Reserved.